Antisense-mediated Redirection of MRNA Splicing
Overview
Affiliations
Antisense technology has been used to study basic biological processes, and to block these processes when they deleteriously lead to human disease. A separate, equally important application of antisense technology is to upregulate the gene expression lost in the diseased state by shifting alternative splicing of pre-messenger RNA. This strategy has commonly relied upon the use of antisense oligonucleotides; however, another approach is to use a plasmid construct to generate antisense RNA inside the cell. Antisense therapeutics based on expression vectors and viral vectors offers a gene therapy approach, whereas those based on oligonucleotides offers a more drug like approach.
Dugovic B, Wagner M, Leumann C Beilstein J Org Chem. 2014; 10:1840-7.
PMID: 25161745 PMC: 4142851. DOI: 10.3762/bjoc.10.194.
Repair of pre-mRNA splicing: prospects for a therapy for spinal muscular atrophy.
Nlend R, Meyer K, Schumperli D RNA Biol. 2010; 7(4):430-40.
PMID: 20523126 PMC: 3070909. DOI: 10.4161/rna.7.4.12206.
Geib T, Hertel K PLoS One. 2009; 4(12):e8204.
PMID: 19997596 PMC: 2781471. DOI: 10.1371/journal.pone.0008204.
Maguire K, Suzuki T, DiMatteo D, Parekh-Olmedo H, Kmiec E BMC Mol Biol. 2009; 10:15.
PMID: 19236710 PMC: 2654480. DOI: 10.1186/1471-2199-10-15.
Laufer S, Restle T Curr Pharm Des. 2008; 14(34):3637-55.
PMID: 19075740 PMC: 2778081. DOI: 10.2174/138161208786898806.